[Table/Fig-2]:
Histology (Malignant Lesions) | No. of Cases |
---|---|
SCCA | 7(43%) |
Adenocarcinoma | 2(12%) |
Lymphoma | 4(25%) |
Rhabdomyosarcoma | 1(6%) |
Esthesioneuroblastoma | 1(6%) |
Malignant melanoma | 1(6%) |
Histology (Malignant Lesions) | No. of Cases |
---|---|
SCCA | 7(43%) |
Adenocarcinoma | 2(12%) |
Lymphoma | 4(25%) |
Rhabdomyosarcoma | 1(6%) |
Esthesioneuroblastoma | 1(6%) |
Malignant melanoma | 1(6%) |